152 related articles for article (PubMed ID: 29472141)
21. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy.
Fedele CG; Polo C; Tenorio A; Niubò J; Ciardi MR; Pérez JL
J Med Virol; 2006 Oct; 78(10):1271-5. PubMed ID: 16927288
[TBL] [Abstract][Full Text] [Related]
22. Cellular and humoral immune response in progressive multifocal leukoencephalopathy.
Weber F; Goldmann C; Krämer M; Kaup FJ; Pickhardt M; Young P; Petry H; Weber T; Lüke W
Ann Neurol; 2001 May; 49(5):636-42. PubMed ID: 11357954
[TBL] [Abstract][Full Text] [Related]
23. JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.
Wharton KA; Quigley C; Themeles M; Dunstan RW; Doyle K; Cahir-McFarland E; Wei J; Buko A; Reid CE; Sun C; Carmillo P; Sur G; Carulli JP; Mansfield KG; Westmoreland SV; Staugaitis SM; Fox RJ; Meier W; Goelz SE
PLoS One; 2016; 11(5):e0155897. PubMed ID: 27191595
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy.
Bayliss J; Karasoulos T; McLean CA
J Infect Dis; 2013 Jan; 207(1):133-6. PubMed ID: 23112281
[TBL] [Abstract][Full Text] [Related]
25. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Iannetta M; Zingaropoli MA; Bellizzi A; Morreale M; Pontecorvo S; D'Abramo A; Oliva A; Anzivino E; Lo Menzo S; D'Agostino C; Mastroianni CM; Millefiorini E; Pietropaolo V; Francia A; Vullo V; Ciardi MR
PLoS One; 2016; 11(8):e0160277. PubMed ID: 27486658
[TBL] [Abstract][Full Text] [Related]
26. TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infection.
Yousef S; Planas R; Chakroun K; Hoffmeister-Ullerich S; Binder TM; Eiermann TH; Martin R; Sospedra M
J Immunol; 2012 Oct; 189(7):3618-30. PubMed ID: 22942431
[TBL] [Abstract][Full Text] [Related]
27. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes.
Steinhardt MJ; Wiercinska E; Pham M; Grigoleit GU; Mazzoni A; Da-Via M; Zhou X; Meckel K; Nickel K; Duell J; Krummenast FC; Kraus S; Hopkinson C; Weissbrich B; Müllges W; Stoll G; Kortüm KM; Einsele H; Bonig H; Rasche L
J Transl Med; 2020 Apr; 18(1):177. PubMed ID: 32316991
[TBL] [Abstract][Full Text] [Related]
28. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
Hou J; Major EO
J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
[TBL] [Abstract][Full Text] [Related]
29. Replication of JC Virus DNA in the G144 Oligodendrocyte Cell Line Is Dependent Upon Akt.
Peterson JN; Lin B; Shin J; Phelan PJ; Tsichlis P; Schwob JE; Bullock PA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768870
[TBL] [Abstract][Full Text] [Related]
30. Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.
Takahashi K; Sekizuka T; Fukumoto H; Nakamichi K; Suzuki T; Sato Y; Hasegawa H; Kuroda M; Katano H
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795410
[TBL] [Abstract][Full Text] [Related]
31. Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.
Fedele CG; Ciardi MR; Delia S; Contreras G; Perez JL; De Oña M; Vidal E; Tenorio A
J Neurovirol; 2003 Oct; 9(5):551-8. PubMed ID: 13129769
[TBL] [Abstract][Full Text] [Related]
32. The basis for modeling progressive multifocal leukoencephalopathy pathogenesis.
Berger JR
Curr Opin Neurol; 2011 Jun; 24(3):262-7. PubMed ID: 21499097
[TBL] [Abstract][Full Text] [Related]
33. Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).
Yang W; Beaudoin EL; Lu L; Du Pasquier RA; Kuroda MJ; Willemsen RA; Koralnik IJ; Junghans RP
Int Immunol; 2007 Sep; 19(9):1083-93. PubMed ID: 17660502
[TBL] [Abstract][Full Text] [Related]
34. Progressive multifocal leukoencephalopathy in patients with chronic kidney disease.
Meylor J; Artunduaga DC; Mendoza M; Hooshmand SI; Obeidat AZ
Neurol Sci; 2024 Apr; 45(4):1619-1624. PubMed ID: 37950135
[TBL] [Abstract][Full Text] [Related]
35. JCV-specific T-cells producing IFN-gamma are differently associated with PmL occurrence in HIV patients and liver transplant recipients.
Agrati C; Izzo L; Berno G; Cimini E; Bordoni V; Giancola ML; Baldini F; Colasanti M; Ettorre GM; Izzo P; Pugliese F; Angrisani M; Di Cello P; Capobianchi MR; Bolognese A
New Microbiol; 2015 Jan; 38(1):85-9. PubMed ID: 25742151
[TBL] [Abstract][Full Text] [Related]
36. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution.
Narula S; LaRosa DF; Kamoun M; Dalmau J; Levinson AI
Ann Allergy Asthma Immunol; 2007 May; 98(5):483-9. PubMed ID: 17521034
[TBL] [Abstract][Full Text] [Related]
37. A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.
Sanjo N; Nose Y; Shishido-Hara Y; Mizutani S; Sekijima Y; Aizawa H; Tanizawa T; Yokota T
J Neurol; 2019 Feb; 266(2):369-377. PubMed ID: 30511098
[TBL] [Abstract][Full Text] [Related]
38. Animal Models for Progressive Multifocal Leukoencephalopathy.
White MK; Gordon J; Berger JR; Khalili K
J Cell Physiol; 2015 Dec; 230(12):2869-74. PubMed ID: 26041694
[TBL] [Abstract][Full Text] [Related]
39. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy.
Sabath BF; Major EO
J Infect Dis; 2002 Dec; 186 Suppl 2():S180-6. PubMed ID: 12424695
[TBL] [Abstract][Full Text] [Related]
40. Rituximab-associated progressive multifocal leukoencephalopathy.
Sokol J; Lisá L; Zeleňáková J; Balhárek T; Plameňová I; Staško J; Kubisz P
Vnitr Lek; 2017; 63(1):60-64. PubMed ID: 28225293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
